At a glance
ClinicalIndex Comparison RecordN/ACompleted· 146 enrolled
Drug / intervention
Bard 5 Fr diameter feeding tubedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Prospective Study to Compare the Incidence of Biliary Complications After Liver Transplantation
In Brief
A clinical study evaluating Bard 5 Fr diameter feeding tube for Liver Transplant; Complications. Completed, enrolled 146 participants across 1 site.
Detailed Summary
A randomized prospective study will be conducted of patients at Vanderbilt University Medical Center who undergo liver transplantation from March 2014 until approximately 120 patients are randomized. Patients will be randomized to undergo biliary reconstruction with and without stent placement.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Transplant; Complications
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
First PostedMay 2017
Primary CompletionSep 2019
TodayJul 2026
First PostedMay 24, 2017
Enrollment StartSep 15, 2014
Primary CompletionSep 30, 2019
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 9.1 years ago
Interventions
Bard 5 Fr diameter feeding tubedevice
A pediatric feeding tube is used as a stent over which biliary anastomosis is performed. This is not a permanent stent and generally migrates out on its own.